What is a common adverse effect of immunotherapy?

What is a common adverse effect of immunotherapy?

• A. Nausea and vomiting only
• B. Immune-related adverse events
• C. Anemia and thrombocytopenia
• D. Hair loss and fatigue

Answer: (B)

Immunotherapy can trigger a unique set of side effects known as immune-related adverse events. This occurs because immunotherapy is designed to enhance the body’s immune response against cancer, but in doing so, it can sometimes lead the immune system to attack normal cells and tissues. As a result, patients may experience a range of autoimmune symptoms that can affect various organs, including the skin, lungs, colons, liver, and endocrine glands, among others. These immune-related adverse events can manifest as dermatitis, pneumonitis, colitis, hepatitis, endocrinopathies, and more, depending on the area of the body that is affected. This differentiates immunotherapy side effects from those typically seen with traditional chemotherapy agents. Conversely, the other options list side effects that are more commonly associated with chemotherapy and are not the hallmark cautions one would associate with immunotherapy, which reinforces the relevance of acknowledging immune-related adverse events as key to understanding the management and expectations surrounding immunotherapy treatment.

Immunotherapy can trigger a unique set of side effects known as immune-related adverse events. This occurs because immunotherapy is designed to enhance the body’s immune response against cancer, but in doing so, it can sometimes lead the immune system to attack normal cells and tissues. As a result, patients may experience a range of autoimmune symptoms that can affect various organs, including the skin, lungs, colons, liver, and endocrine glands, among others.

These immune-related adverse events can manifest as dermatitis, pneumonitis, colitis, hepatitis, endocrinopathies, and more, depending on the area of the body that is affected. This differentiates immunotherapy side effects from those typically seen with traditional chemotherapy agents.

Conversely, the other options list side effects that are more commonly associated with chemotherapy and are not the hallmark cautions one would associate with immunotherapy, which reinforces the relevance of acknowledging immune-related adverse events as key to understanding the management and expectations surrounding immunotherapy treatment.